Philips Wins $33.7M ARPA-H Award for Robotic Stroke Care
Cambridge, Massachusetts, United States & Amsterdam, Netherlands, Aug 26, 2026 Royal Philips has received an award of up to...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Cambridge, Massachusetts, United States & Amsterdam, Netherlands, Aug 26, 2026 Royal Philips has received an award of up to...
JACKSONVILLE, Fla., July 30, 2026 Medical Microinstruments (MMI) announced that the U.S. Food and Drug Administration (FDA) has approved...
Riyadh, Saudi Arabia | July 21, 2026 King Faisal Specialist Hospital and Research Centre (KFSH) has achieved a global...
ST. LOUIS and ROUEN, France, July 9, 2026 Stereotaxis announced the successful completion of its previously announced acquisition of...
